RETINITIS PIGMENTOSA (RP)
Clinical trials for RETINITIS PIGMENTOSA (RP) explained in plain language.
Never miss a new study
Get alerted when new RETINITIS PIGMENTOSA (RP) trials appear
Sign up with your email to follow new studies for RETINITIS PIGMENTOSA (RP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a blood injection save your sight? new study hopes so
Disease control OngoingThis early-phase study tests whether injecting a concentrated form of a patient's own blood (platelet-rich plasma) around the eye can help preserve vision in people with retinitis pigmentosa or a related retinal disease called EMAP. Thirty adults will receive three injections ove…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase: PHASE1, PHASE2 • Sponsor: Rubens Camargo Siqueira • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can a single drug slow vision loss in rare eye diseases?
Disease control OngoingThis early-phase study tests whether an anti-inflammatory drug (adalimumab) injected into the eye can help preserve vision in people with retinitis pigmentosa or a related condition called EMAP. Thirty adults will receive three injections over four months, and researchers will me…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase: PHASE1, PHASE2 • Sponsor: Centro de Pesquisa Rubens Siqueira • Aim: Disease control
Last updated May 13, 2026 16:01 UTC